Understanding the Current Rating
The Strong Sell rating assigned to Deep Health AI India Ltd indicates a cautious stance for investors, signalling significant concerns about the stock’s near-term prospects. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment and helps investors understand the risks and challenges associated with the stock.
Quality Assessment
As of 14 August 2026, Deep Health AI India Ltd’s quality grade remains below average. The company continues to report operating losses, which undermines its long-term fundamental strength. Its ability to service debt is notably weak, with an average EBIT to interest ratio of just 1.00, indicating limited earnings before interest and taxes relative to interest obligations. This financial fragility raises concerns about the company’s capacity to sustain operations without significant restructuring or capital infusion.
Valuation Perspective
Currently, the stock is considered expensive relative to its fundamentals. Despite trading at a price-to-book value of 0.6, which suggests a discount compared to peers’ historical valuations, the company’s return on equity (ROE) stands at 13.4%, reflecting moderate profitability. However, the valuation is tempered by the stock’s high dividend yield of 5.1%, which may attract income-focused investors but also signals potential risk if earnings do not support sustainable payouts. The PEG ratio is reported as zero, highlighting a disconnect between price and earnings growth expectations.
Financial Trend Analysis
The financial trend for Deep Health AI India Ltd is flat, with recent quarterly results showing no improvement. As of June 2026, the company posted a net loss after tax (PAT) of ₹2.15 crores, a dramatic fall of 3683.3% compared to previous periods. Earnings before depreciation, interest, and taxes (PBDIT) and profit before tax less other income (PBT less OI) also hit their lowest levels at ₹2.06 crores and ₹2.32 crores respectively. These figures underscore ongoing operational challenges and lack of profitability momentum.
Technical Outlook
The technical grade for the stock is bearish, reflecting negative market sentiment and price momentum. Over the past year, Deep Health AI India Ltd has delivered a return of -47.62%, significantly underperforming the BSE500 benchmark in each of the last three annual periods. The stock’s recent price movements show a 6-month decline of 45.00% and a year-to-date drop of 66.33%, signalling sustained selling pressure and weak investor confidence.
Performance Summary
As of 14 August 2026, the stock’s performance metrics paint a challenging picture. The one-day change is flat at 0.00%, but the one-week and one-month returns are negative at -1.49% and -2.46% respectively. The three-month return is down by 16.81%, while the six-month and year-to-date figures show steep declines. This consistent underperformance against the benchmark highlights the stock’s vulnerability in the current market environment.
Implications for Investors
For investors, the Strong Sell rating suggests that Deep Health AI India Ltd carries considerable risk and may not be suitable for those seeking capital appreciation or stable income in the near term. The combination of weak fundamentals, expensive valuation relative to earnings quality, flat financial trends, and bearish technical signals advises caution. Investors should carefully weigh these factors against their risk tolerance and investment horizon before considering exposure to this stock.
Sector and Market Context
Operating within the Gems, Jewellery and Watches sector, Deep Health AI India Ltd is classified as a microcap company. This segment often experiences volatility due to fluctuating consumer demand and global economic conditions. The company’s ongoing operating losses and weak debt servicing capacity further compound sector-specific risks, making it imperative for investors to monitor developments closely.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Long-Term Outlook and Considerations
While the current rating and data suggest a cautious approach, investors should remain vigilant for any changes in the company’s operational performance or market conditions that could alter its outlook. Improvements in profitability, debt servicing ability, or technical momentum could warrant a reassessment of the stock’s rating. Until such developments occur, the prevailing view remains that Deep Health AI India Ltd is best avoided by risk-averse investors.
Summary
In summary, Deep Health AI India Ltd’s Strong Sell rating as of 11 February 2026 reflects a comprehensive evaluation of its below-average quality, expensive valuation, flat financial trends, and bearish technical indicators. The latest data as of 14 August 2026 confirms ongoing challenges, including significant losses, weak debt coverage, and sustained underperformance against market benchmarks. Investors should consider these factors carefully when making portfolio decisions involving this stock.
About MarketsMOJO Ratings
MarketsMOJO’s ratings are designed to provide investors with a clear, data-driven assessment of stocks based on multiple dimensions of analysis. The Strong Sell rating signals a high level of risk and advises investors to avoid or exit positions in the stock. This rating is part of a broader framework that includes Buy, Hold, Sell, Strong Buy, and Strong Sell categories, each reflecting varying degrees of confidence in a company’s prospects.
Final Note
It is important to remember that all financial metrics, returns, and fundamentals discussed here are current as of 14 August 2026 and not from the rating update date of 11 February 2026. This ensures investors have the most recent and relevant information to guide their investment decisions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
